2017
DOI: 10.1016/j.jval.2017.08.373
|View full text |Cite
|
Sign up to set email alerts
|

Orphan Drug Reimbursement In Europe: Do Less Stringent Regulatory Requirements Translate Into Less Favourable Reimbursement?

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles